UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Primitive sarcoma of the breast: new insight on the proper surgical management

Journal of experimental & clinical cancer research, 2015-07, Vol.34 (1), p.72-72, Article 72

2015

Link zum Volltext

Verfügbarkeit prüfen

Maintenance immunotherapy in stage IV cancer patients who have a clinical benefit from chemotherapy

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3021-3021

2017

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in Patients with Less than Complete Response to Chemotherapy

Anticancer research, 2009-02, Vol.29 (2), p.567-572

2009

Link zum Volltext

Verfügbarkeit prüfen

Prolonged Disease Control after Myeloablative Chemotherapy, Autologous Transplantation and Immunotherapy in High-risk Early Breast Cancer

Anticancer research, 2010-01, Vol.30 (1), p.209-216

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT109: Adjuvant ovarian suppression in high risk premenopausal breast cancer: ten-year follow-up of a phase I-II study

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT109-CT109

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase II Randomized Study of Interleukin-2 with or without 13-cis Retinoic Acid as Maintenance Therapy in Patients with Advanced Cancer Responsive to Chemotherapy

Anticancer research, 2005-07, Vol.25 (4), p.3149-3157

2005

Link zum Volltext

Verfügbarkeit prüfen

Dose-finding Study of Docetaxel Added to Ifosfamide and Cisplatin Followed by Concomitant Capecitabine and Radiotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Anticancer research, 2006-05, Vol.26 (3B), p.2317-2324

2006

Link zum Volltext

Verfügbarkeit prüfen

LH-RH analogues in the treatment of young women with early breast cancer: Long-term follow-up of a phase II study

International journal of oncology, 2015-03, Vol.46 (3), p.1354-1360

2015

Link zum Volltext

Verfügbarkeit prüfen

Maintenance immunotherapy in patients with advanced cancer (AC): Long term follow-up of a phase II study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14005-e14005

2015

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel Plus Gemcitabine in Advanced Non-small Cell Lung Cancer Patients with Low Performance Status

Anticancer research, 2005-01, Vol.25 (1B), p.409-414

2005

Link zum Volltext

Verfügbarkeit prüfen

Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin-eluting beads compared with lipiodol

Oncology reports, 2012-05, Vol.27 (5), p.1377-1383

2012

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer

Anticancer research, 2015-12, Vol.35 (12), p.6847-6853

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT301: Late disease recurrence in estrogen receptor positive (ER+) premenopausal breast cancer (BC)

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.CT301-CT301

2014

Link zum Volltext

Verfügbarkeit prüfen

Gonadotropin‐releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma

Cancer, 2006-02, Vol.106 (3), p.514-523

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5366: Extended phase II study of maintenance immunotherapy in advanced cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5366-5366

2012

Link zum Volltext

Verfügbarkeit prüfen

Total estrogen blockade and chemotherapy in high-risk premenopausal early breast cancer (BC): Long-term follow-up of a phase II study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.537-537

2014

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin Fractionated Over Two Days with Bimonthly Leucovorin and 5-Fluorouracil in Metastatic Colorectal Cancer

Anticancer research, 2004-05, Vol.24 (3B), p.1935-1940

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5055: The role of estrogens and vascular endothelial growth factor (VEGF) in premenopausal breast cancer carginogenesis and disease progression

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5055-5055

2011

Link zum Volltext

Verfügbarkeit prüfen

Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study

Gynecologic oncology, 2010-02, Vol.116 (2), p.202-207

2010

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, open-label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high-risk, early breast cancer (HRBC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e11041-e11041

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 480: Maintenance immunotherapy following carboplatin (CBDCA) - pemetrexed (PEM) chemotherapy in advanced adenocarcinoma (ADK) of the lung: A phase II study

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.480-480

2013

Link zum Volltext

Verfügbarkeit prüfen

Beta-interferon, retinoids and tamoxifen in metastatic breast cancer : Long-term follow-up of a phase II study

Oncology reports, 2009-04, Vol.21 (4), p.1011-1016

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3722: Ovarian suppression with gonadotropin-releasing hormone analogues (Gn-RH) in high risk premenopausal breast cancer patients (PM-HR-BC): decrease of T regulatory cells (T-regs) and of vascular endothelial growth factor (VEGF)

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3722-3722

2010

Link zum Volltext

Verfügbarkeit prüfen

Premenopausal Hormone-responsive Breast Cancer with Extensive Axillary Nodes Involvement: Total Estrogen Blockade and Chemotherapy

Anticancer research, 2011-02, Vol.31 (2), p.671-676

2011

Link zum Volltext

Verfügbarkeit prüfen

Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer

Oncology letters, 2013-04, Vol.5 (4), p.1117-1122

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(92)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(64)
Humans
(59)
Female
(54)
Middle Aged
(51)
Adult
(44)
Oncology
(44)
Aged
(42)
Male
(39)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(31)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(20)
Tumors
(19)
Chemotherapy
(16)
Treatment Outcome
(16)
Aged, 80 And Over
(13)
Antineoplastic Agents
(13)
Pharmacology. Drug Treatments
(13)
Disease-Free Survival
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Primitive sarcoma of the breast: new insight on the proper surgical management

Maintenance immunotherapy in stage IV cancer patients who have a clinical benefit from chemotherapy

Immunotherapy in Patients with Less than Complete Response to Chemotherapy

Prolonged Disease Control after Myeloablative Chemotherapy, Autologous Transplantation and Immunotherapy in High-risk Early Breast Cancer

Abstract CT109: Adjuvant ovarian suppression in high risk premenopausal breast cancer: ten-year follow-up of a phase I-II study

Phase II Randomized Study of Interleukin-2 with or without 13-cis Retinoic Acid as Maintenance Therapy in Patients with Advanced Cancer Responsive to Chemotherapy

Dose-finding Study of Docetaxel Added to Ifosfamide and Cisplatin Followed by Concomitant Capecitabine and Radiotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck

LH-RH analogues in the treatment of young women with early breast cancer: Long-term follow-up of a phase II study

Maintenance immunotherapy in patients with advanced cancer (AC): Long term follow-up of a phase II study

Paclitaxel Plus Gemcitabine in Advanced Non-small Cell Lung Cancer Patients with Low Performance Status

Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin-eluting beads compared with lipiodol

Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer

Abstract CT301: Late disease recurrence in estrogen receptor positive (ER+) premenopausal breast cancer (BC)

Gonadotropin‐releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma

Abstract 5366: Extended phase II study of maintenance immunotherapy in advanced cancer

Total estrogen blockade and chemotherapy in high-risk premenopausal early breast cancer (BC): Long-term follow-up of a phase II study

Oxaliplatin Fractionated Over Two Days with Bimonthly Leucovorin and 5-Fluorouracil in Metastatic Colorectal Cancer

Abstract 5055: The role of estrogens and vascular endothelial growth factor (VEGF) in premenopausal breast cancer carginogenesis and disease progression

Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study

A multicenter, open-label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high-risk, early breast cancer (HRBC)

Abstract 480: Maintenance immunotherapy following carboplatin (CBDCA) - pemetrexed (PEM) chemotherapy in advanced adenocarcinoma (ADK) of the lung: A phase II study

Beta-interferon, retinoids and tamoxifen in metastatic breast cancer : Long-term follow-up of a phase II study

Abstract 3722: Ovarian suppression with gonadotropin-releasing hormone analogues (Gn-RH) in high risk premenopausal breast cancer patients (PM-HR-BC): decrease of T regulatory cells (T-regs) and of vascular endothelial growth factor (VEGF)

Premenopausal Hormone-responsive Breast Cancer with Extensive Axillary Nodes Involvement: Total Estrogen Blockade and Chemotherapy

Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer

Suchergebnisse filtern